Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 10/2018

01-10-2018 | Literatur kommentiert

Hochrisiko-Endometriumkarzinom: Immer eine adjuvante Radiochemotherapie?

Authors: Felix Bock, Prof. Dr. med. Guido Hildebrandt

Published in: Strahlentherapie und Onkologie | Issue 10/2018

Login to get access

Auszug

Gegenstand der vorliegenden multizentrischen, prospektiven Phase-III-Studie von de Boer et al. ist, mögliche Vorteile durch eine Chemotherapie während und nach einer adjuvanten Radiotherapie (RT) im Vergleich zu einer alleinigen adjuvanten Strahlentherapie bei Patientinnen mit einem Hochrisiko-Endometriumkarzinom zu erfassen. …
Literature
1.
Denschlag D (2011) Diagnostik und Therapie des Endometriumkarzinoms. Dtsch Arztebl 108:34–35
2.
Randall ME et al (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24:36–44CrossRef
3.
Maggi R et al (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95:266–271CrossRef
Metadata
Title
Hochrisiko-Endometriumkarzinom: Immer eine adjuvante Radiochemotherapie?
Authors
Felix Bock
Prof. Dr. med. Guido Hildebrandt
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 10/2018
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1351-x

Other articles of this Issue 10/2018

Strahlentherapie und Onkologie 10/2018 Go to the issue

Original Article

Stereotactic radiotherapy for choroidal melanomas by means of HybridArc™

Editorial

Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math

Literatur kommentiert

Die Radiotherapie des Pleuramesothelioms – Klinische Praxisleitlinie der American Society of Clinical Oncology

Original Article

Automatic replanning of VMAT plans for different treatment machines: A template-based approach using constrained optimization

Original Article

MRI-based high-precision irradiation in an orthotopic pancreatic tumor mouse model

Original Article

Early versus late prophylactic cranial irradiation in patients with extensive small cell lung cancer